acetylcarnitine has been researched along with Apoplexy in 1 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sixty-nine cases with acute ischemic stroke with the onset of symptoms less than 24 hours not candidates for reperfusion therapy were randomly assigned to either the ALC group (1000 mg three times per day for three consecutive days) or the matching placebo group." | 3.11 | Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial. ( Abolfathi, P; Mazdeh, M; Mehrpooya, M; Mohammadi, Y; Sabetghadam, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mazdeh, M | 1 |
| Abolfathi, P | 1 |
| Sabetghadam, M | 1 |
| Mohammadi, Y | 1 |
| Mehrpooya, M | 1 |
1 trial available for acetylcarnitine and Apoplexy
| Article | Year |
|---|---|
Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial.
Topics: Acetylcarnitine; Antioxidants; Biomarkers; Brain Ischemia; Humans; Iran; Ischemic Stroke; Stroke; Tr | 2022 |